Skip to main content
Premium Trial:

Request an Annual Quote

George Yancopoulos

Cold Spring Harbor Laboratory has appointed George Yancopoulos to its board of trustees. He currently serves as chief scientific officer of Regeneron Pharmaceuticals and president of Regeneron Laboratories. He joined Regeneron in 1989 as its scientific founder. Together with key members of his team, he is a principal inventor and developer of Regeneron’s four FDA-approved drugs.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.